Abstract
Objective
To evaluate the occurrence and severity of oral complications, number of radiotherapy (RT) interruptions and quality of life (QoL) in a population of head and neck cancer patients receiving a preventive oral care program (POCP) and photobiomodulation therapy (PBMT).
Methods
Prospective cohort of 61 head and neck cancer patients undergoing radiochemotherapy were monitored and submitted to a POCP that included oral hygiene and plaque control, removal of infection foci, dental restorations, periodontal therapy, fluorotherapy, oral hydration, and denture removal at night, combined with daily PBMT. Outcomes included occurrence of adverse effects such as severity of oral mucositis (OM) and oral symptoms (pain, solid and fluid dysphagia, odynophagia, dysgeusia), quality of life impacts, and interruptions of radiotherapy (RT) due to symptoms. Disease-free and overall survival rates were evaluated.
Results
There was a significant improvement in oral health conditions between initial assessment and the two longitudinal assessments (p < 0.05), which indicates that the POCP was effective for plaque control and reduction of gingival inflammation. All participants were free of OM at the beginning of the RT regimen and only 45.9% after the 7th session, and few patients ranked the highest score of OM. For all symptoms related to OM, there was a progressive increase of severity until the 14th RT session, which remained stable until the completion of the RT regimen. The same effect was observed for the quality of life measures. Discontinued RT due to OM occurred in only three patients (5%), and the maximum duration was 10 days. The overall survival rate was 77% and disease-free survival was 73.8%. Lower survival time was observed for patients with no response to RT (p < 0.01).
Conclusions
The findings of this study suggest a positive effect of an oral preventive care program for head and neck cancer patients submitted to RT. The PBMT associated with a rigorous POCP resulted in satisfactory control of oral adverse effects, reduction of quality of life impacts, and interruption of RT regimen due to severe OM.
Similar content being viewed by others
References
Vera-Llonch M, Oster G, Hagiwara M, Sonis S (2006) Oral mucositis in patients undergoing radiation treatment for head and neck carcinoma. Cancer 106:329–336. https://doi.org/10.1002/cncr.21622
González Ferreira JA, Jaén Olasolo J, Azinovic I, Jeremic B (2015) Effect of radiotherapy delay in overall treatment time on local control and survival in head and neck cancer: review of the literature. Reports Pract Oncol Radiother 20:328–339. https://doi.org/10.1016/j.rpor.2015.05.010
Maciá I, Garau M, Solé Monné J, Cambra Serés MJ et al (2009) Compliance to the prescribed overall treatment time (OTT) of curative radiotherapy in normal clinical practice and impact on treatment duration of counteracting short interruptions by treating patients on Saturdays. Clin Transl Oncol 11:302–311. https://doi.org/10.1007/s12094-009-0358-2
Cheng KK-F, Leung SF, Liang RHS et al (2010) Severe oral mucositis associated with cancer therapy: impact on oral functional status and quality of life. Support Care Cancer 18:1477–1485. https://doi.org/10.1007/s00520-009-0771-7
Morais MO, Abrahao Elias MR, Leles CR et al (2016) The effect of preventive oral care on treatment outcomes of a cohort of oral cancer patients. Support Care Cancer 24:1663–1670. https://doi.org/10.1007/s00520-015-2956-6
Carneiro-Neto JN, De-Menezes JD d S, Moura LB et al (2017) Protocols for management of oral complications of chemotherapy and/or radiotherapy for oral cancer: systematic review and meta-analysis current. Med Oral Patol Oral Cir Bucal 22:e15–e23. https://doi.org/10.4317/medoral.21314
Frydrych A, Slack-Smith L, Parsons R (2017) Compliance of post-radiation therapy head and neck cancer patients with caries preventive protocols. Aust Dent J 62:192–199. https://doi.org/10.1111/adj.12491
Kubota K, Kobayashi W, Sakaki H, Nakagawa H, Kon T, Mimura M, Ito R, Furudate K, Kimura H (2015) Professional oral health care reduces oral mucositis pain in patients treated by superselective intra-arterial chemotherapy concurrent with radiotherapy for oral cancer. Support Care Cancer 23:3323–3329. https://doi.org/10.1007/s00520-015-2774-x
Bowen JM, Elad S, Hutchins RD, Lalla RV (2013) Methodology for the MASCC/ISOO mucositis clinical practice guidelines update. Support Care Cancer 21:303–308. https://doi.org/10.1007/s00520-012-1592-7
Lalla RV, Bowen J, Barasch A, Elting L, Epstein J, Keefe DM, McGuire D, Migliorati C, Nicolatou-Galitis O, Peterson DE, Raber-Durlacher JE, Sonis ST, Elad S, Mucositis Guidelines Leadership Group of the Multinational Association of Supportive Care in Cancer and International Society of Oral Oncology (MASCC/ISOO) (2014) MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy. Cancer 120:1453–1461. https://doi.org/10.1002/cncr.28592
McGuire DB, Fulton JS, Park J, Brown CG, Correa ME, Eilers J, Elad S, Gibson F, Oberle-Edwards LK, Bowen J, Lalla RV, Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO) (2013) Systematic review of basic oral care for the management of oral mucositis in cancer patients. Support Care Cancer 21:3165–3177. https://doi.org/10.1007/s00520-013-1942-0
Saunders DP, Epstein JB, Elad S, Allemano J, Bossi P, van de Wetering M, Rao NG, Potting C, Cheng KK, Freidank A, Brennan MT, Bowen J, Dennis K, Lalla RV, Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO) (2013) Systematic review of antimicrobials, mucosal coating agents, anesthetics, and analgesics for the management of oral mucositis in cancer patients. Support Care Cancer 21:3191–3207. https://doi.org/10.1007/s00520-013-1871-y
Nicolatou-Galitis O, Sarri T, Bowen J, di Palma M, Kouloulias VE, Niscola P, Riesenbeck D, Stokman M, Tissing W, Yeoh E, Elad S, Lalla RV, Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO) (2013) Systematic review of anti-inflammatory agents for the management of oral mucositis in cancer patients. Support Care Cancer 21:3179–3189. https://doi.org/10.1007/s00520-013-1847-y
Oton-Leite AF, Elias LSA, Morais MO, Pinezi JC, Leles CR, Silva MA, Mendonça EF (2013) Effect of low level laser therapy in the reduction of oral complications in patients with cancer of the head and neck submitted to radiotherapy. Spec Care Dentist 33:294–300. https://doi.org/10.1111/j.1754-4505.2012.00303.x
Oton-Leite AFAF, Silva GBL, Morais MOMO, Silva TA, Leles CR, Valadares MC, Pinezi JC, Batista AC, Mendonça EF (2015) Effect of low-level laser therapy on chemoradiotherapy-induced oral mucositis and salivary inflammatory mediators in head and neck cancer patients. Lasers Surg Med 47:296–305. https://doi.org/10.1002/lsm.22349
Antunes HS, Herchenhorn D, Small IA, Araújo CM, Viégas CM, Cabral E, Rampini MP, Rodrigues PC, Silva TG, Ferreira EM, Dias FL, Ferreira CG (2013) Phase III trial of low-level laser therapy to prevent oral mucositis in head and neck cancer patients treated with concurrent chemoradiation. Radiother Oncol 109:297–302. https://doi.org/10.1016/j.radonc.2013.08.010
Gautam AP, Fernandes DJ, Vidyasagar MS, Maiya AG, Nigudgi S (2013) Effect of low-level laser therapy on patient reported measures of oral mucositis and quality of life in head and neck cancer patients receiving chemoradiotherapy—a randomized controlled trial. Support Care Cancer 21:1421–1428. https://doi.org/10.1007/s00520-012-1684-4
Gautam AP, Fernandes DJ, Vidyasagar MS, Maiya AG, Vadhiraja BM (2012) Low level laser therapy for concurrent chemoradiotherapy induced oral mucositis in head and neck cancer patients – a triple blinded randomized controlled trial. Radiother Oncol 104:349–354. https://doi.org/10.1016/j.radonc.2012.06.011
Gonnelli FAS, Palma LF, Giordani AJ, Deboni AL, Dias RS, Segreto RA, Segreto HR (2016) Low-level laser for mitigation of low salivary flow rate in head and neck cancer patients undergoing radiochemotherapy: a prospective longitudinal study. Photomed Laser Surg 34:326–330. https://doi.org/10.1089/pho.2016.4104
von Elm E, Altman DG, Egger M et al (2007) STROBE Initiative. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. PLoS Med 4:e296
Oken M, Creech R, Tormey D et al (1982) Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5:649–656
Eilers J, Berger AM, Petersen MC (1988) Development, testing, and application of the oral assessment guide. Oncol Nurs Forum 15:325–330
American Dental Association and American Academy of Periodontology (1993) Periodontal screening & recording an early detection system. J N J Dent Assoc 64(7–9):11
O’Leary TJ, Drake RB, Naylor JE (1972) The plaque control record. J Periodontol 43:38. https://doi.org/10.1902/jop.1972.43.1.38
Kushner JA, Lawrence HP, Shoval I et al (2008) Development and validation of a Patient-Reported Oral Mucositis Symptom (PROMS) scale. J Can Dent Assoc 74:59
da Mata A, da Silva Marques DN, Freitas F, de Almeida Rato Amaral JP, Trindade RT, Barcelos FA, Vaz Patto JM (2012) Translation, validation, and construct reliability of a Portuguese version of the Xerostomia Inventory. Oral Dis 18:293–298. https://doi.org/10.1111/j.1601-0825.2011.01879.x
Oliveira BH, Nadanovsky P (2005) Psychometric properties of the Brazilian version of the Oral Health Impact Profile-short form. Community Dent Oral Epidemiol 33:307–314. https://doi.org/10.1111/j.1600-0528.2005.00225.x
Kashiwazaki H, Matsushita T, Sugita J, Shigematsu A, Kasashi K, Yamazaki Y, Kanehira T, Yamamoto S, Kondo T, Endo T, Tanaka J, Hashino S, Nishio M, Imamura M, Kitagawa Y, Inoue N (2012) Professional oral health care reduces oral mucositis and febrile neutropenia in patients treated with allogeneic bone marrow transplantation. Support Care Cancer 20:367–373. https://doi.org/10.1007/s00520-011-1116-x
Düzkaya DS, Uysal G, Bozkurt G, Yakut T (2017) The effect of oral care using an oral health care guide on preventing mucositis in pediatric intensive care. J Pediatr Nurs 36:98–102. https://doi.org/10.1016/j.pedn.2017.05.010
Gautam AP, Fernandes DJ, Vidyasagar MS et al (2015) Low level laser therapy against radiation induced oral mucositis in elderly head and neck cancer patients-a randomized placebo controlled trial. J Photochem Photobiol B Biol 144:51–56. https://doi.org/10.1016/j.jphotobiol.2015.01.011
Bjordal JM, Bensadoun R-J, Tunèr J, Frigo L, Gjerde K, Lopes-Martins RA (2011) A systematic review with meta-analysis of the effect of low-level laser therapy (LLLT) in cancer therapy-induced oral mucositis. Support Care Cancer 19:1069–1077. https://doi.org/10.1007/s00520-011-1202-0
Peng H, Chen B-B, Chen L, Chen YP, Liu X, Tang LL, Mao YP, Li WF, Zhang Y, Lin AH, Sun Y, Ma J (2017) A network meta-analysis in comparing prophylactic treatments of radiotherapy-induced oral mucositis for patients with head and neck cancers receiving radiotherapy. Oral Oncol 75:89–94. https://doi.org/10.1016/j.oraloncology.2017.11.001
Simões A, de Campos L, de Souza DN, de Matos JA, Freitas PM, Nicolau J (2010) Laser phototherapy as topical prophylaxis against radiation-induced xerostomia. Photomed Laser Surg 28:357–363. https://doi.org/10.1089/pho.2009.2486
González-Arriagada WA, Ramos LMA, Andrade MAC, Lopes MA (2017) Efficacy of low-level laser therapy as an auxiliary tool for management of acute side effects of head and neck radiotherapy. J Cosmet Laser Ther:1–6. https://doi.org/10.1080/14764172.2017.1376097
Romeo U, Del Vecchio A, Capocci M et al (2010) The low level laser therapy in the management of neurological burning mouth syndrome. A pilot study Ann Stomatol (Roma) 1:14–18
Antunes HS, Schluckebier LF, Herchenhorn D, Small IA, Araújo CM, Viégas CM, Rampini MP, Ferreira EM, Dias FL, Teich V, Teich N, Ferreira CG (2016) Cost-effectiveness of low-level laser therapy (LLLT) in head and neck cancer patients receiving concurrent chemoradiation. Oral Oncol 52:85–90. https://doi.org/10.1016/j.oraloncology.2015.10.022
Gouvêa De Lima A, Villar RC, De Castro G et al (2012) Oral mucositis prevention by low-level laser therapy in head-and-neck cancer patients undergoing concurrent chemoradiotherapy: a phase III randomized study. Int J Radiat Oncol Biol Phys 82:270–275. https://doi.org/10.1016/j.ijrobp.2010.10.012
Oton-Leite AF, Corrêa de Castro AC, Morais MO, Pinezi JC, Leles CR, Mendonça EF (2012) Effect of intraoral low-level laser therapy on quality of life of patients with head and neck cancer undergoing radiotherapy. Head Neck 34:398–404. https://doi.org/10.1002/hed.21737
Tiwari V, Mahawar R (2017) Squamous cell carcinoma of the buccal mucosa: a single institute retrospective analysis of nodal involvement and survival. Gulf J Oncolog 1:46–50
Xu Q, Wang C, Li B, Li JZ, Mao MH, Qin LZ, Li H, Huang X, Han Z, Feng Z (2018) Prognostic value of pathologic grade for patients with oral squamous cell carcinoma. Oral Dis 24:335–346. https://doi.org/10.1111/odi.12727
Masoudi S, Montazeri SA, Pourdanesh F, Biglarian A, Kazemi M, Rahgozar M (2017) A new approach to survival analysis of head and neck squamous cell carcinoma. Arch Iran Med 20:503–510
Masood M, Masood Y, Saub R, Newton JT (2014 Winter) Need of minimal important difference for oral health-related quality of life measures. J Public Health Dent 74(1):13–20
Acknowledgments
The authors wish to thank the Hospital Araújo Jorge – Combat Cancer Association (HAJ-ACCG) and Foundation for Research Support of the State of Goiás (DECIT/SCTIE/MS/CNPq/FAPEG - Protocol 12/2013; process 201410267000312).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
This prospective observational study was conducted in the Araujo Jorge Hospital (Association of Combat Cancer in Goias), in Goiania, Brazil, and was approved by the local research ethics committee (approval no. 012/12).
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
ESM 1
(DOC 85 kb)
Rights and permissions
About this article
Cite this article
Morais, M.O., Martins, A.F.L., de Jesus, A.P.G. et al. A prospective study on oral adverse effects in head and neck cancer patients submitted to a preventive oral care protocol. Support Care Cancer 28, 4263–4273 (2020). https://doi.org/10.1007/s00520-019-05283-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00520-019-05283-1